Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau(181), and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

Ju-Hee Kang, David J Irwin, Alice S. Chen-Plotkin, Andrew Siderowf, Chelsea Caspell, Christopher S Coffey, Teresa Waligórska, Peggy Taylor, Sarah Pan, Mark Frasier, Kenneth Marek, Karl Kieburtz, Danna Jennings, Tanya Simuni, Caroline M. Tanner, Andrew B. Singleton, Arthur W Toga, Sohini Chowdhury, Brit Mollenhauer, John Q. TrojanowskiLeslie M Shaw, Parkinson's Progression Markers Initiative, Dominic Rowe

    Research output: Contribution to journalArticlepeer-review

    336 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau(181), and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease'. Together they form a unique fingerprint.

    Medicine & Life Sciences